Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-09-11
2007-09-11
Chang, Celia (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S208000
Reexamination Certificate
active
10492347
ABSTRACT:
Provided is a compound having excellent dipeptidyl peptidase IV-inhibiting activity, and a remedy based on the activity for insulin-dependent diabetes (type 1 diabetes), especially for non insulin-dependent diabetes (type 2 diabetes), insulin-resistant disorders, and obesity.
REFERENCES:
patent: 6166063 (2000-12-01), Villhauer
patent: 2004/0063935 (2004-04-01), Yasuda et al.
patent: 2004/0072892 (2004-04-01), Fukushima et al.
patent: 2004/0242636 (2004-12-01), Haffner et al.
patent: 2005/0130981 (2005-06-01), Aranyl et al.
patent: WO98/19998 (1998-05-01), None
patent: WO 01/55105 (2001-08-01), None
patent: WO 01/96295 (2001-12-01), None
patent: WO 03/000250 (2003-01-01), None
patent: WO 03/000253 (2003-01-01), None
Hayakawa Masahiko
Maruyama Tatsuya
Miyamoto Satoshi
Nakano Ryosuke
Negoro Kenji
Chang Celia
Finnegan Henderson Farabow Garrett & Dunner LLP
Yamanouchi Pharmaceutical Co. Ltd.
LandOfFree
2-cyano-4-fluoropyrrolidine derivative or its salt does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 2-cyano-4-fluoropyrrolidine derivative or its salt, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2-cyano-4-fluoropyrrolidine derivative or its salt will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3794413